InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by TILTON GLENN F, Director. Insider active across 3 companies, notably AbbVie Inc.. In total, 7 disclosures have been logged. The latest transaction was filed on 6 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
01,421 shares0
Common Stock, $0.01 par value
SEC:0001179110-22-002932:0·
01,602 shares0
Common shares without par value
SEC:0001415889-22-004558:0·
22,500 shares
Common Stock
SEC:0001534701-22-000086:0·
€174,5732,284 shares@ €76.43290.0003% mcap100.0% of flow
Common Stock
SEC:0001534701-22-000006·
€174,5732,284 shares@ €76.43290.0003% mcap50.0% of flow
Common Stock
SEC:0001534701-22-000006:0·
01,681 shares0
Common Stock, $0.01 par value
SEC:0001179110-21-005208·
01,681 shares0
Common Stock, $0.01 par value
SEC:0001179110-21-005208:0·
7 of 7 declarations
About TILTON GLENN F
Glenn F. Tilton is a Director at AbbVie Inc., Phillips 66, and ABBOTT LABORATORIES. He plays a key role in the governance and strategy of the companies.
